After crossing the 95 percent threshold in Vexim, Stryker plans to file a public buy-out offer followed by a squeeze-out for outstanding Vexim shares.
Spinal Tech
Here are 16 key notes on orthopedic and spine device companies from the past week.
Mazor Robotics reported full year 2017 revenue at $64.9 million, including its investment from Medtronic for Mazor X systems. Mazor has now invested around $72 million in Mazor and taken over marketing efforts for the product; the companies will develop…
Stryker named Kevin Lobo CEO in October 2012. Here are five things to know about him:
Vik Kapoor, MD, a Medovex medical advisory board member, presented initial data from his DenerveX System study.
Advertisement
Enrollment started for a study testing Orthofix's RCStim device as an adjunctive treatment to surgically mending full thickness rotator cuff tears.
Medtronic hired Gregory Zimprich to serve as the director of finance communications, according to PR Week.
Surgeons performed the first procedures using Camber Spine's SPIRA-C Open Matrix Cervical Interbody device.
Here are five quotes from Johnson & Johnson CEO Alex Gorsky on where the company's medical device and healthcare businesses are headed, based on his statement during the fourth quarter 2017 conference call as transcribed by Seeking Alpha:
The global neurosurgical products market is anticipated to grow at a 10.5 percent compound annual growth rate through 2023, according to Wise Guy Reports.